Stock comparison
Side-by-side financials for CSTL and GH. Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
GH is larger
Market cap data is available for the leading company in this comparison.
Market value leader
GH
Latest market capitalization comparison.
Revenue leader
GH
CSTL: $344.23M vs GH: $982.02M.
Profit leader
CSTL
CSTL: -$24.16M vs GH: -$416.30M.
Margin leader
CSTL
CSTL: -7.0% vs GH: -42.4% net margin.
| Metric | CSTL | GH |
|---|---|---|
| Market cap | - | $21.22 B |
| US-listed rank | - | #604 |
| Revenue (latest FY) | $344.23M | $982.02M |
| Net income (latest FY) | -$24.16M | -$416.30M |
| Net margin | -7.0% | -42.4% |
| P/E (trailing FY) | - | - |
| SEC filings | 828 | 1,131 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
In their latest fiscal years, CASTLE BIOSCIENCES INC reported $344.23M in revenue while Guardant Health, Inc. reported $982.02M.
Full pages: CASTLE BIOSCIENCES INC and Guardant Health, Inc., or browse the full rankings.